(en) Dressler, Bright et Polito, « Exploring the relationship between microdosing, personality and emotional insight: A prospective study », Journal of Psychedelic Studies, vol. 5, no 1, , p. 9–16 (DOI10.1556/2054.2021.00157, lire en ligne)
« Phase 0/microdosing approaches: time for mainstream application in drug development? », Nature Reviews. Drug Discovery, vol. 19, no 11, , p. 801–818 (PMID32901140, DOI10.1038/s41573-020-0080-x)
« Late-Stage Carbon-14 Labeling and Isotope Exchange: Emerging Opportunities and Future Challenges », JACS Au, vol. 2, no 6, , p. 1234–1251 (PMID35783167, PMCID9241029, DOI10.1021/jacsau.2c00030)
« Conversion of the LLNL/CAMS 1 MV biological AMS system to a semi-automated natural abundance 14C spectrometer: system optimization and performance evaluation », Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol. 499, , p. 124–132 (PMID38344059, PMCID10854407, DOI10.1016/j.nimb.2021.01.022, Bibcode2021NIMPB.499..124B)
(en) Dressler, Bright et Polito, « Exploring the relationship between microdosing, personality and emotional insight: A prospective study », Journal of Psychedelic Studies, vol. 5, no 1, , p. 9–16 (DOI10.1556/2054.2021.00157, lire en ligne)
« Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development », Clinical and Translational Science, vol. 9, no 2, , p. 74–88 (PMID26918865, PMCID5351314, DOI10.1111/cts.12390)
« A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers », British Journal of Clinical Pharmacology, vol. 84, no 3, , p. 482–489 (PMID29168205, PMCID5809343, DOI10.1111/bcp.13476)
« Conversion of the LLNL/CAMS 1 MV biological AMS system to a semi-automated natural abundance 14C spectrometer: system optimization and performance evaluation », Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol. 499, , p. 124–132 (PMID38344059, PMCID10854407, DOI10.1016/j.nimb.2021.01.022, Bibcode2021NIMPB.499..124B)
« Phase 0/microdosing approaches: time for mainstream application in drug development? », Nature Reviews. Drug Discovery, vol. 19, no 11, , p. 801–818 (PMID32901140, DOI10.1038/s41573-020-0080-x)
« Late-Stage Carbon-14 Labeling and Isotope Exchange: Emerging Opportunities and Future Challenges », JACS Au, vol. 2, no 6, , p. 1234–1251 (PMID35783167, PMCID9241029, DOI10.1021/jacsau.2c00030)
« Conversion of the LLNL/CAMS 1 MV biological AMS system to a semi-automated natural abundance 14C spectrometer: system optimization and performance evaluation », Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, vol. 499, , p. 124–132 (PMID38344059, PMCID10854407, DOI10.1016/j.nimb.2021.01.022, Bibcode2021NIMPB.499..124B)
« Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development », Clinical and Translational Science, vol. 9, no 2, , p. 74–88 (PMID26918865, PMCID5351314, DOI10.1111/cts.12390)
« A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers », British Journal of Clinical Pharmacology, vol. 84, no 3, , p. 482–489 (PMID29168205, PMCID5809343, DOI10.1111/bcp.13476)